Calcineurin—the missing link in cardiac hypertrophy (original) (raw)

Nature Medicine volume 4, pages 661–662 (1998)Cite this article

Transgenic mice that overexpress calcineurin develop cardiac hypertrophy, which can be prevented by treatment with immunosuppressive drugs that inhibit calcineurin.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Molkentin, J.D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215–228 (1998).
    Article CAS Google Scholar
  2. Sadoshima, J. & Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59, 551–571 (1997).
    Article CAS Google Scholar
  3. Gruver, C.L., DeMayo, F., Goldstein, M.A. & Means, A.R. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 133, 376–388 (1993).
    Article CAS Google Scholar
  4. Morgan, J.P., Erny, R.E., Allen, P.D., Grossman, W. & Gwathmey, J.K. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 81, 21–32 (1990).
    Google Scholar
  5. Takahashi, T. et al. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J. Clin. Invest. 90, 927–935 (1992).
    Article CAS Google Scholar
  6. Herzig, T.C. et al. Angiotensin II type 1α receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc. Natl. Acad. Sci. USA 94, 7543–7548 (1997).
    Article CAS Google Scholar
  7. Rao, A., Luo, C. & Hogan, P.G. Transcription factors of the NF-AT family: Regulation and function. Annu. Rev. Immunol. 15, 707–747 (1997).
    Article CAS Google Scholar
  8. Schreiber, S.L. & Crabtree, G.R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136–142 (1992).
    Article CAS Google Scholar
  9. Katz, A.M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N. Engl. J. Med. 322, 100–110 (1990).
    Article CAS Google Scholar
  10. Dolmetsch, R.E., Lewis, R.S., Goodnow, C.C. & Healy, J.I. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386, 855–858 (1997).
    Article CAS Google Scholar
  11. Mason, J.W. et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N. Engl. J. Med. 333, 269–275 (1995).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, 02215, USA
    Seigo Izumo & Hiroki Aoki

Authors

  1. Seigo Izumo
    You can also search for this author inPubMed Google Scholar
  2. Hiroki Aoki
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Izumo, S., Aoki, H. Calcineurin—the missing link in cardiac hypertrophy.Nat Med 4, 661–662 (1998). https://doi.org/10.1038/nm0698-661

Download citation

This article is cited by